semaglutide griffin GloFusion Clinic (@glofusionclinic) • Facebook Even With Access to Blockbuster

Ongoing #GLP1 -RA Trials on #ASCVD #SELECT: Semaglutide vs Placebo in Patients With Obesity and ASCVD Without DM #SOUL: Semaglutide vs Placebo in Adults With T2D With ASCVD or CKD #SURPASS-CVOT: Tirzepatide vs Dulaglutide in Patients With T2D and ASCVD #SURMOUNT-MMO:

Which next-gen weight loss peptide is right for you in Canada

Ships to USA, Canada, Australia, UK & Europe.

IQVIA Payer Control Library The Bottom Line The GLP-1 market sits at the intersection of clinical innovation and patient behavior, where real-world persistence often falls short of therapeutic potential

#Semaglutide improves heart failure-related symptoms and physical function and results in greater weight loss compared with placebo in patients with #HFpEF and #obesity #ESCCongress STEP-HFpEF trial